Independence Day 2026: From the Swadeshi movement to Atmanirbhar Bharat. Early Swadeshi movements fostered indigenous industries against im...

During the first quarter of fiscal 2027, India's pharmaceutical exports soared to $8.10 billion, showcasing remarkable strength in drug for...

The Indian supplements market is anticipated to soar to nearly fifty-seven billion dollars by twenty thirty, driven by heightened consumer ...

India's pharmaceutical exports to the UK are set to witness substantial growth thanks to the recently negotiated Comprehensive Economic and...

Indian pharmaceutical exports to the United Kingdom are projected to grow significantly. The India-UK Comprehensive Economic and Trade Agre...

NPPA has informed that it has not received any reference from pharma associations regarding steep increase in price of medicines due to out...

As per the information received from the port offices of the Central Drugs Standard Control Organisation (CDSCO), it stood at 12,006.11 met...

The National Pharmaceutical Pricing Authority (NPPA) has also revised the prices of three formulations, including that of anti cancer drug ...

As per the notification the prices of formulations including Ciprofloxacin Hydrochloride, Cefotaxime, Paracetamol, Domperidone and Metformi...

The recommendations are being examined for formulation of a policy for promotion of manufacturing of bulk drugs.

These drugs include commonly-used antibiotics and painkillers as well as medicines used for treating cancer and skin disorders.

Export of pharmaceutical products from India are set to cross Rs 1 lakh crore mark this fiscal from Rs 90,000 crore during fiscal .

The drug price regulator has asked pharmaceutical companies to disclose quarterly data on the amount of essential drugs they are producing.

Vadodara-based drug maker, Alembic Pharmaceuticals Ltd registered annual net profit rise of 27% largely due to domestic business.

Drugs are expected to cost more due to hike in excise duty to 6% from 5% on formulations and to 12% from 10% on bulk drugs announced by FM ...

The government may agree to price increases in 70 scheduled drugs and revise those of several bulk drugs.

NEW DELHI: The Pharmaceutical Policy, 2002, has accepted the Drug Price Control Review Committee's suggestion that low-cost drugs measured ...